The just-released final FDA rule to create a unique identifier system for medical devices has received positive response from AdvaMed. "While we are still reviewing all the details of the final rule, AdvaMed commends FDA for addressing many of the concerns industry raised in the proposed rule," said Janet Trunzo, AdvaMed's senior executive vice president of technology and regulatory affairs.
AdvaMed responds to final device identifier rule
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||